These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 26283687)

  • 1. Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment.
    Jour G; Illa-Bochaca I; Ibrahim M; Donnelly D; Zhu K; Miera EV; Vasudevaraja V; Mezzano V; Ramswami S; Yeh YH; Winskill C; Betensky RA; Mehnert J; Osman I
    J Invest Dermatol; 2023 Mar; 143(3):444-455.e8. PubMed ID: 35988589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
    Hyman DM; Puzanov I; Subbiah V; Faris JE; Chau I; Blay JY; Wolf J; Raje NS; Diamond EL; Hollebecque A; Gervais R; Elez-Fernandez ME; Italiano A; Hofheinz RD; Hidalgo M; Chan E; Schuler M; Lasserre SF; Makrutzki M; Sirzen F; Veronese ML; Tabernero J; Baselga J
    N Engl J Med; 2015 Aug; 373(8):726-36. PubMed ID: 26287849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting brain tumor cAMP: the case for sex-specific therapeutics.
    Warrington NM; Sun T; Rubin JB
    Front Pharmacol; 2015; 6():153. PubMed ID: 26283963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
    Shain AH; Garrido M; Botton T; Talevich E; Yeh I; Sanborn JZ; Chung J; Wang NJ; Kakavand H; Mann GJ; Thompson JF; Wiesner T; Roy R; Olshen AB; Gagnon A; Gray JW; Huh N; Hur JS; Busam KJ; Scolyer RA; Cho RJ; Murali R; Bastian BC
    Nat Genet; 2015 Oct; 47(10):1194-9. PubMed ID: 26343386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells.
    Korkut A; Wang W; Demir E; Aksoy BA; Jing X; Molinelli EJ; Babur Ö; Bemis DL; Onur Sumer S; Solit DB; Pratilas CA; Sander C
    Elife; 2015 Aug; 4():. PubMed ID: 26284497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The paradox of cancer genes in non-malignant conditions: implications for precision medicine.
    Adashek JJ; Kato S; Lippman SM; Kurzrock R
    Genome Med; 2020 Feb; 12(1):16. PubMed ID: 32066498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NF1 gene in tumor syndromes and melanoma.
    Kiuru M; Busam KJ
    Lab Invest; 2017 Feb; 97(2):146-157. PubMed ID: 28067895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
    Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
    Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.
    Krauthammer M; Kong Y; Bacchiocchi A; Evans P; Pornputtapong N; Wu C; McCusker JP; Ma S; Cheng E; Straub R; Serin M; Bosenberg M; Ariyan S; Narayan D; Sznol M; Kluger HM; Mane S; Schlessinger J; Lifton RP; Halaban R
    Nat Genet; 2015 Sep; 47(9):996-1002. PubMed ID: 26214590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma.
    Mahalingam M
    Adv Anat Pathol; 2017 Jan; 24(1):1-14. PubMed ID: 27941538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.
    Thielmann CM; Chorti E; Matull J; Murali R; Zaremba A; Lodde G; Jansen P; Richter L; Kretz J; Möller I; Sucker A; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Paschen A; Livingstone E; Zimmer L; Schadendorf D; Hadaschik E; Ugurel S; Griewank KG
    Eur J Cancer; 2021 Dec; 159():113-124. PubMed ID: 34742158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.
    Cirenajwis H; Lauss M; Ekedahl H; Törngren T; Kvist A; Saal LH; Olsson H; Staaf J; Carneiro A; Ingvar C; Harbst K; Hayward NK; Jönsson G
    Mol Oncol; 2017 Apr; 11(4):438-451. PubMed ID: 28267273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF1 Mutations Prevalent but Not Clinically Relevant.
    Cancer Discov; 2015 Oct; 5(10):OF1. PubMed ID: 26283687
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.